Literature DB >> 33036026

Germline PAX5 mutation predisposes to familial B-cell precursor acute lymphoblastic leukemia.

Nicolas Duployez1,2, Laura A Jamrog3, Vincent Fregona3, Camille Hamelle3, Laurène Fenwarth1,2, Sophie Lejeune4, Nathalie Helevaut1,2, Sandrine Geffroy1,2, Aurélie Caillault1,2, Alice Marceau-Renaut1,2, Stéphanie Poulain1,2, Catherine Roche-Lestienne2,5, Laetitia Largeaud3,6, Naïs Prade3,6, Stéphanie Dufrechou3,6, Sylvie Hébrard3, Céline Berthon2,7, Brigitte Nelken8, José Fernandes9, Céline Villenet10, Martin Figeac10, Bastien Gerby3, Eric Delabesse3,6, Claude Preudhomme1,2, Cyril Broccardo3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33036026     DOI： 10.1182/blood.2020005756

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  8 in total

1.  Variant to function mapping at single-cell resolution through network propagation.

Authors:  Fulong Yu; Liam D Cato; Chen Weng; L Alexander Liggett; Soyoung Jeon; Keren Xu; Charleston W K Chiang; Joseph L Wiemels; Jonathan S Weissman; Adam J de Smith; Vijay G Sankaran
Journal:  Nat Biotechnol       Date:  2022-06-06       Impact factor: 54.908

2.  Identification of novel, clonally stable, somatic mutations targeting transcription factors PAX5 and NKX2-3, the epigenetic regulator LRIF1, and BRAF in a case of atypical B-cell chronic lymphocytic leukemia harboring a t(14;18)(q32;q21).

Authors:  Bénédicte Burlet; Selim Ramla; Cyril Fournier; Maria Jimena Abrey-Recalde; Camille Sauter; Marie-Lorraine Chrétien; Cédric Rossi; Yannis Duffourd; Sylviane Ragot; Céline Buriller; Benjamin Tournier; Caroline Chapusot; Nathalie Nadal; Jessica Racine; Julien Guy; François Bailly; Laurent Martin; Olivier Casasnovas; Jean-Noël Bastie; Denis Caillot; Juliette Albuisson; Cyril Broccardo; Catherine Thieblemont; Laurent Delva; Marc Maynadié; Romain Aucagne; Mary B Callanan
Journal:  Cold Spring Harb Mol Case Stud       Date:  2021-02-19

Review 3.  Antibiotics in early life and childhood pre-B-ALL. Reasons to analyze a possible new piece in the puzzle.

Authors:  T M Cardesa-Salzmann; A Simon; N Graf
Journal:  Discov Oncol       Date:  2022-01-10

Review 4.  Forward and Reverse Genetics of B Cell Malignancies: From Insertional Mutagenesis to CRISPR-Cas.

Authors:  Joanna C Dawes; Anthony G Uren
Journal:  Front Immunol       Date:  2021-08-13       Impact factor: 7.561

Review 5.  In Utero Development and Immunosurveillance of B Cell Acute Lymphoblastic Leukemia.

Authors:  Nadine Rüchel; Vera H Jepsen; Daniel Hein; Ute Fischer; Arndt Borkhardt; Katharina L Gössling
Journal:  Curr Treat Options Oncol       Date:  2022-03-16

Review 6.  Review of guidelines for the identification and clinical care of patients with genetic predisposition for hematological malignancies.

Authors:  Brigitte Schlegelberger; Cristina Mecucci; Marcin Wlodarski
Journal:  Fam Cancer       Date:  2021-05-31       Impact factor: 2.375

7.  Toward prevention of childhood ALL by early-life immune training.

Authors:  Julia Hauer; Ute Fischer; Arndt Borkhardt
Journal:  Blood       Date:  2021-10-21       Impact factor: 22.113

8.  Variant to function mapping at single-cell resolution through network propagation.

Authors:  Fulong Yu; Liam D Cato; Chen Weng; L Alexander Liggett; Soyoung Jeon; Keren Xu; Charleston W K Chiang; Joseph L Wiemels; Jonathan S Weissman; Adam J de Smith; Vijay G Sankaran
Journal:  bioRxiv       Date:  2022-01-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.